Example: Heart Attack

Search clinical trials for: Temozolomide

Total 897 results

NCT04467346

Not yet recruiting

Bioequivalence Study Between Temozolomide Oral Suspension (Ped-TMZ) and Temodal® Capsules

Conditions: Therapeutic Equivalency
NCT04462965

Recruiting

Postoperative Adjuvant Treatment of Completely Resected Mucosal Melanoma Phase II Study

Conditions: Mucosal Melanoma
NCT04457284

Not yet recruiting

Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer

Conditions: Colorectal Adenocarcinoma
NCT04450160

Not yet recruiting

Trial of AEO in New Glioblastoma (GBM)

Conditions: Glioblastoma Multiforme
NCT04443010

Not yet recruiting

Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma

Conditions: Glioblastoma
NCT04434482

Not yet recruiting

IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer

Conditions: Advanced Solid Tumours; Small Cell Lung Cancer
NCT04430842

Recruiting

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Conditions: Astrocytoma; Brain Cancer; Brain Metastases; Bladder Cancer; Breast Cancer; Cervical Cancer; Cholangiocarcinoma; Colorectal Cancer; Esophagus Cancer; Gastric Cancer; Head and Neck Cancer; Kidney Cancer; Liver Cancer; Lung Cancer; Melanoma; Ovarian Cancer; Pancreatic Cancer; Pleural Mesothelioma; Prostate Cancer; Sarcoma; Tongue Cancer; Thymic Carcinoma; Urinary Tract Cancer
NCT04421378

Recruiting

A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma

Conditions: Glioblastoma Multiforme
NCT04400188

Recruiting

A Study of Fluzoparib (SHR-3162) and Temozolomide With or Without SHR-1316 in Treating Patients With Replapsed Small Cell Lung Cancer

Conditions: Small Cell Lung Cancer
NCT04396860

Not yet recruiting

Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma

Conditions: Gliosarcoma; MGMT-Unmethylated Glioblastoma
NCT04397679

Not yet recruiting

Partial Brain Radiation Therapy, Temozolomide, Chloroquine, and Tumor Treating Fields Therapy for the Treatment of Newly Diagnosed Glioblastoma

Conditions: Glioblastoma; Gliosarcoma
NCT04397770

Not yet recruiting

Camrelizumab Plus Apatinib and Temozolomide as First Line Therapy in Advanced Acral Melanoma

Conditions: Melanoma
NCT04394858

Not yet recruiting

Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer

Conditions: Advanced Adrenal Gland Pheochromocytoma; Advanced Paraganglioma; Metastatic Adrenal Gland Pheochromocytoma; Metastatic Paraganglioma; Unresectable Adrenal Gland Pheochromocytoma; Unresectable Paraganglioma
NCT04388033

Recruiting

Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.

Conditions: Glioblastoma; Glioma; Neoplasms, Neuroepithelial; Neuroectodermal Tumors; Neoplasms; Neoplasms, Nerve Tissue; Vaccines; Immunologic Factors
NCT04388475

Recruiting

Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma

Conditions: Recurrent Malignant Glioma; Brain Glioblastoma
NCT04385173

Recruiting

Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma

Conditions: Recurrent Glioblastoma; Refractory Glioblastoma
NCT04385277

Not yet recruiting

Treatment With Dinutuximab in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma

Conditions: Ganglioneuroblastoma, Nodular; High-Risk Neuroblastoma
NCT04373785

Not yet recruiting

NG101m Adjuvant Therapy in Glioblastoma Patients

Conditions: Newly Diagnosed Glioblastoma Multiforme
NCT04339036

Not yet recruiting

Study of Capecitabine-Temozolomide(CapTem) With Yttrium-90 in Patients With Unresectable Metastatic Grade 2 Neuroendocrine Tumors

Conditions: Neuroendocrine Tumor Grade 2; Neuroendocrine Tumors
NCT04337177

Not yet recruiting

Flavored, Oral Irinotecan (VAL-413) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors

Conditions: Solid Tumors; Neuroblastoma; Rhabdomyosarcoma; Ewing Sarcoma; Hepatoblastoma; Medulloblastoma
NCT04324840

Not yet recruiting

A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Subjects With Newly Diagnosed Glioblastoma

Conditions: Glioblastoma
NCT04316039

Recruiting

Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade Gliomas After Surgery

Conditions: Low-grade Glioma
NCT04313842

Recruiting

A Explorative Study to Evaluate the Clinical Feasibility of AVATAMED

Conditions: Glioblastoma
NCT04308330

Recruiting

Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies

Conditions: Ewing Sarcoma; Rhabdomyosarcoma; Wilms Tumor; Neuroblastoma; Hepatoblastoma; Germ Cell Tumor
NCT04303988

Not yet recruiting

A Multi-cohort Phase II Study of HER2-positive and Triple-negative Breast Cancer Brain Metastases.

Conditions: Breast Cancer
NCT04280848

Recruiting

Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma

Conditions: Glioblastoma
NCT04267978

Not yet recruiting

Study of Recombinant Human Endostatin Combined With Temozolomide and Irinotecan in Recurrent Gliomas

Conditions: Glioblastoma, Recurrent; Lower Grade Glioma, Recurrent
NCT04267146

Recruiting

Nivolumab in Combination With Temozolomide and Radiotherapy in Children and Adolescents With Newly Diagnosed High-grade Glioma

Conditions: High Grade Glioma
NCT04253873

Recruiting

Clinical Study of Apatinib Combined With Temozolomide in the Treatment of Uncontrolled or Repeated High-grade Gliomas

Conditions: High-grade Gliomas
NCT04250922

Recruiting

2-OHOA With RT and TMZ for Adults With Glioblastoma

Conditions: Primary Glioblastoma; Glioblastoma Multiforme
NCT04244708

Not yet recruiting

The Effect of Chemoradiotherapy in Patients With Refractory Pituitary Adenomas

Conditions: Pituitary Adenomas
NCT04238819

Not yet recruiting

A Study of Abemaciclib (LY2835219) in Combination With Temozolomide and Irinotecan and Abemaciclib in Combination With Temozolomide in Children and Young Adult Participants With Solid Tumors

Conditions: Relapsed Solid Tumor; Refractory Solid Tumor
NCT04224441

Recruiting

Repurposing Chlorpromazine in the Treatment of Glioblastoma

Conditions: Glioblastoma Multiforme; MGMT-Unmethylated Glioblastoma
NCT04219475

Not yet recruiting

Predicting Response Patterns to Treatment in Glioblastoma (GBM) Patients

Conditions: Glioblastoma
NCT04218019

Not yet recruiting

Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation

Conditions: Newly Diagnosed Glioblastoma in Patients ≥70 Years
NCT04216329

Recruiting

Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma

Conditions: Gliosarcoma; Newly Diagnosed; Glioblastoma
NCT04211675

Not yet recruiting

NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Conditions: Relapsed Neuroblastoma; Refractory Neuroblastoma
NCT04209790

Not yet recruiting

Neoadjuvant Chemoradiation for Resectable Glioblastoma

Conditions: Glioblastoma; Surgery; High Grade Glioma
NCT04200066

Not yet recruiting

A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma

Conditions: Glioblastoma; Brain Tumor
NCT04200443

Recruiting

Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma

Conditions: Metastatic Leiomyosarcoma; Metastatic Soft Tissue Sarcoma; Stage III Uterine Corpus Leiomyosarcoma AJCC v8; Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8; Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8; Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8; Stage IV Uterine Corpus Leiomyosarcoma AJCC v8; Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8; Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8; Unresectable Leiomyosarcoma; Unresectable Soft Tissue Sarcoma
NCT04199026

Not yet recruiting

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

Conditions: Metastatic Sarcoma; Recurrent Sarcoma; Resectable Sarcoma
NCT04194125

Recruiting

Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer

Conditions: Neuroendocrine Tumors
NCT04195139

Recruiting

Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM

Conditions: Glioblastoma Multiforme
NCT04165941

Recruiting

Novel Gamma-Delta (γδ)T Cell Therapy for Treatment of Patients With Newly Diagnosed Glioblastoma

Conditions: Brain Tumor Adult
NCT04166435

Recruiting

TMZ + Olaparib for MGMT Hypermethylated Colorectal Cancer

Conditions: Colorectal Cancer
NCT04157478

Not yet recruiting

Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma

Conditions: Glioblastoma
NCT04135807

Recruiting

Implantable Microdevice In Primary Brain Tumors

Conditions: Grade II Glioma; Grade III Glioma; Grade IV Glioma; Astrocytoma; Oligodendroglioma of Brain; Anaplastic Astrocytoma of Brain; Anaplastic Oligodendroglioma; Glioblastoma
NCT04122911

Completed

Temozolomide for Second-Line Treatment of Neuroendocrine Carcinomas

Conditions: Neuroendocrine Carcinomas
NCT04119674

Recruiting

Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma

Conditions: Glioblastoma
NCT04116411

Recruiting

A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients

Conditions: Glioblastoma Multiforme